|
MilliporeSigma to distribute Expansorb polymers
August 2016
SHARING OPTIONS:
BILLERICA, Mass.—MilliporeSigma
and PCAS S.A. have joined forces in an agreement to expand MilliporeSigma’s excipients
portfolio. Though no financial details were disclosed, the agreement stipulates that MilliporeSigma will be the exclusive global distributor of the Expansorb
line of biocompatible and biodegradable polymers. This portfolio includes 38 polymers for sustained release of small-molecule and selected peptide
injectables. The Expansorb PLA and PLGA polymers are manufactured by PCAS under cGMP conditions and will be sold under MilliporeSigma’s Emprove program
once the appropriate evaluations and certifications are complete.
“The pharmaceutical industry is increasingly
interested in controlling the release of small molecules and selected peptides delivered via injection,” said Andrew Bulpin, MilliporeSigma’s
head of Process Solutions. “The addition of the Expansorb polymers to our broad portfolio of excipients improves drug developers’ ability to
protect molecules with short in-vivo half-lives and achieve the desired therapeutic effect while enhancing patient comfort and
compliance.”
Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|